Literature DB >> 27716661

Genetic Prion Disease Caused by PRNP Q160X Mutation Presenting with an Orbitofrontal Syndrome, Cyclic Diarrhea, and Peripheral Neuropathy.

Jamie C Fong1, Julio C Rojas1, Jee Bang1, Andrea Legati2, Katherine P Rankin1, Sven Forner1, Zachary A Miller1, Anna M Karydas1, Giovanni Coppola2, Carrie K Grouse3, Jeffrey Ralph3, Bruce L Miller1, Michael D Geschwind1.   

Abstract

Patients with pathogenic truncating mutations in the prion gene (PRNP) usually present with prolonged disease courses with severe neurofibrillary tangle and cerebral amyloidosis pathology, but more atypical phenotypes also occur, including those with dysautonomia and peripheral neuropathy. We describe the neurological, cognitive, neuroimaging, and electrophysiological features of a 31-year-old man presenting with an orbitofrontal syndrome, gastrointestinal symptoms, and peripheral neuropathy associated with PRNP Q160X nonsense mutation, with symptom onset at age 27. The mutation was also detected in his asymptomatic father and a symptomatic paternal cousin; several members of prior generations died from early onset dementia. This is the first report of a family affected with the nonsense PRNP mutation Q160X displaying clear autosomal dominant disease in multiple family members and reduced penetrance. This case strengthens the evidence suggesting an association between PRNP truncating mutations and prion systemic amyloidosis. PRNP gene testing should be considered in any patient with atypical dementia, especially with early onset and neuropathy, even in the absence of a family history.

Entities:  

Keywords:  Amyloidosis; DNA sequencing; dysautonomia; exome; mutation; peripheral neuropathy; prion dementia

Mesh:

Substances:

Year:  2017        PMID: 27716661      PMCID: PMC5149415          DOI: 10.3233/JAD-160300

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  28 in total

1.  High frequency of mutations in four different disease genes in early-onset dementia.

Authors:  U Finckh; T Müller-Thomsen; U Mann; C Eggers; J Marksteiner; W Meins; G Binetti; A Alberici; P Sonderegger; C Hock; R M Nitsch; A Gal
Journal:  Ann N Y Acad Sci       Date:  2000       Impact factor: 5.691

2.  High prevalence of pathogenic mutations in patients with early-onset dementia detected by sequence analyses of four different genes.

Authors:  U Finckh; T Müller-Thomsen; U Mann; C Eggers; J Marksteiner; W Meins; G Binetti; A Alberici; C Hock; R M Nitsch; A Gal
Journal:  Am J Hum Genet       Date:  2000-01       Impact factor: 11.025

3.  A 54-year-old man with slowness of movement and confusion.

Authors:  Michael D Geschwind; Keith A Josephs; Joseph E Parisi; B Mark Keegan
Journal:  Neurology       Date:  2007-11-06       Impact factor: 9.910

4.  Homozygous prion protein genotype predisposes to sporadic Creutzfeldt-Jakob disease.

Authors:  M S Palmer; A J Dryden; J T Hughes; J Collinge
Journal:  Nature       Date:  1991-07-25       Impact factor: 49.962

5.  Prion protein amyloidosis with divergent phenotype associated with two novel nonsense mutations in PRNP.

Authors:  Casper Jansen; Piero Parchi; Sabina Capellari; Ad J Vermeij; Patrizia Corrado; Frank Baas; Rosaria Strammiello; Willem A van Gool; John C van Swieten; Annemieke J M Rozemuller
Journal:  Acta Neuropathol       Date:  2009-11-13       Impact factor: 17.088

Review 6.  Prion diseases.

Authors:  Leonel T Takada; Michael D Geschwind
Journal:  Semin Neurol       Date:  2013-11-14       Impact factor: 3.420

Review 7.  Frontal-subcortical circuits and human behavior.

Authors:  J L Cummings
Journal:  Arch Neurol       Date:  1993-08

8.  Vascular variant of prion protein cerebral amyloidosis with tau-positive neurofibrillary tangles: the phenotype of the stop codon 145 mutation in PRNP.

Authors:  B Ghetti; P Piccardo; M G Spillantini; Y Ichimiya; M Porro; F Perini; T Kitamoto; J Tateishi; C Seiler; B Frangione; O Bugiani; G Giaccone; F Prelli; M Goedert; S R Dlouhy; F Tagliavini
Journal:  Proc Natl Acad Sci U S A       Date:  1996-01-23       Impact factor: 11.205

9.  A novel familial prion disease causing pan-autonomic-sensory neuropathy and cognitive impairment.

Authors:  K Matsuzono; Y Ikeda; W Liu; T Kurata; S Deguchi; K Deguchi; K Abe
Journal:  Eur J Neurol       Date:  2013-05       Impact factor: 6.089

10.  A novel prion disease associated with diarrhea and autonomic neuropathy.

Authors:  Simon Mead; Sonia Gandhi; Janice L Holton; John Collinge; Jon Beck; Diana Caine; Dillip Gallujipali; Christopher Carswell; Harpreet Hyare; Susan Joiner; Hilary Ayling; Tammaryn Lashley; Jacqueline M Linehan; Huda Al-Doujaily; Bernadette Sharps; Tamas Revesz; Malin K Sandberg; Mary M Reilly; Martin Koltzenburg; Alastair Forbes; Peter Rudge; Sebastian Brandner; Jason D Warren; Jonathan D F Wadsworth; Nicholas W Wood
Journal:  N Engl J Med       Date:  2013-11-14       Impact factor: 91.245

View more
  6 in total

Review 1.  Genetic PrP Prion Diseases.

Authors:  Mee-Ohk Kim; Leonel T Takada; Katherine Wong; Sven A Forner; Michael D Geschwind
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-05-01       Impact factor: 10.005

Review 2.  Prion Proteins Without the Glycophosphatidylinositol Anchor: Potential Biomarkers in Neurodegenerative Diseases.

Authors:  Valerija Kovač; Vladka Čurin Šerbec
Journal:  Biomark Insights       Date:  2018-02-06

3.  Two novel PRNP truncating mutations broaden the spectrum of prion amyloidosis.

Authors:  Sabina Capellari; Simone Baiardi; Rita Rinaldi; Anna Bartoletti-Stella; Claudio Graziano; Silvia Piras; Giovanna Calandra-Buonaura; Roberto D'Angelo; Camilla Terziotti; Raffaele Lodi; Vincenzo Donadio; Loris Pironi; Pietro Cortelli; Piero Parchi
Journal:  Ann Clin Transl Neurol       Date:  2018-04-26       Impact factor: 4.511

4.  Structure of Tau filaments in Prion protein amyloidoses.

Authors:  Grace I Hallinan; Md Rejaul Hoq; Manali Ghosh; Frank S Vago; Anllely Fernandez; Holly J Garringer; Ruben Vidal; Wen Jiang; Bernardino Ghetti
Journal:  Acta Neuropathol       Date:  2021-06-14       Impact factor: 17.088

Review 5.  Characterization of mutations in PRNP (prion) gene and their possible roles in neurodegenerative diseases.

Authors:  Eva Bagyinszky; Vo Van Giau; Young Chul Youn; Seong Soo A An; SangYun Kim
Journal:  Neuropsychiatr Dis Treat       Date:  2018-08-14       Impact factor: 2.570

6.  Evaluating drug targets through human loss-of-function genetic variation.

Authors:  Eric Vallabh Minikel; Konrad J Karczewski; Hilary C Martin; Beryl B Cummings; Nicola Whiffin; Daniel Rhodes; Jessica Alföldi; Richard C Trembath; David A van Heel; Mark J Daly; Stuart L Schreiber; Daniel G MacArthur
Journal:  Nature       Date:  2020-05-27       Impact factor: 49.962

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.